Skip to content

Neonatal Outcome of Children With Antenatal Colic Hyperechogenicity

Neonatal Outcome of Children With Antenatal Colic Hyperechogenicity

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04983069
Acronym
COLONECHOGENE
Enrollment
400
Registered
2021-07-30
Start date
2021-07-01
Completion date
2022-05-01
Last updated
2021-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colic, Nephropathy

Keywords

Gynecology-Obstetrics, Ultrasound, Medical genetics, Pediatrics, Nephropathy, Colic hyperechogenicity, Antenatal, Lysinuria-cystinuria, lysinuric protein intolerance

Brief summary

Fetal colic hyper-echogenicity is a presenting symptoms for cystinuria lysinuria. A few cases of fetuses with dibasic protein intolerance (more complex prognosis) presented with colic hyper-echogenicity antenatal. The aim of this retrospective study is to assess the outcome of fetuses with colic hyperechogenicity in order to increase prenatal counseling

Detailed description

Observational multicenter retrospective study from january 2011 to january 2021. No supplementary visit, directly related to the research, will be necessary. This study does not change the usual management of the patient. Patients will be included after their usual medical check-up.

Interventions

None listed

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
15 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Fetuses with prenatal colic hyperechogenicity * Between January 2011 and January 2021 * Born without term limitation.

Exclusion criteria

* Intestinal hyperechogenicity * polymalformative syndrome * Patients Age\<15 years

Design outcomes

Primary

MeasureTime frameDescription
Postnatal outcome of fetusesday 1 (End of follow up)Postnatal outcome of fetuses with hyperechogenic colon.

Secondary

MeasureTime frameDescription
Rate of lysinuria/cystinuriaday 1 (End of follow up)Rate of lysinuria/cystinuria
Rate of dibasic protein intoleranceday 1 (End of follow up)Rate of dibasic protein intolerance

Countries

France

Contacts

Primary ContactFlorent FUCHS, PhD
f-fuchs@chu-montpellier.fr04 67 33 09 80
Backup ContactAlexis RODRIGUEZ, resident
alexis-rodriguez@chu-montpellier.fr668591043

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026